JAK1 Gene Polymorphisms Are Associated with the Outcomes of Hepatitis B Virus Infection, but Not with α Interferon Therapy Response in a Han Chinese Population
Authors:
- 17 August 2012
- journal article
- research article
- Published by SAGE Publications in Genetic Testing and Molecular Biomarkers
- Vol. 16 (10) , 1206-1210
Abstract
Aims: Janus kinase 1 (JAK1) is a key member in the interferon (IFN) signaling pathway. Recent studies suggested single-nucleotide polymorphisms (SNPs) in IFN pathway genes are associated with outcomes of hepatitis B virus (HBV) infection and response to IFNα therapy. The aim of the study is to investigate whether SNPs in JAK1 were associated with outcomes of HBV infection and response to IFNα therapy. Methods: We enrolled 395 chronic hepatitis B (CHB) patients and 251 subjects with the inactive carrier state, and 256 CHB patients who received IFNα treatment, with therapy efficacy evaluated. Twelve SNPs: rs310227, rs7531799, rs7546545, rs17127174, rs3790541, rs10493373, rs2780898, rs310247, rs310196, rs2780895, rs4244165, and rs17127024 in JAK1, which could represent all SNPs with minor allele frequency >0.2 recorded in the HapMap database were genotyped using a polymerase chain reaction-restriction fragment length polymorphism protocol and the TaqMan method. Results: SNP rs17127024 was associated with outcomes of HBV infection in an allele frequency ( p =0.014) and genotype distributions ( p =0.031), while SNP rs4244165 was associated with outcomes of HBV infection only in genotype distributions ( p =0.008). There were no significant differences in allele frequencies and genotype distributions of these SNPs between the response group and the nonresponse group to IFNα therapy. Conclusions: SNPs rs4244165 and rs17127024 in JAK1 were associated with outcomes of HBV infection, but not with response to IFNα therapy.Keywords
This publication has 21 references indexed in Scilit:
- JAKs in pathology: Role of Janus kinases in hematopoietic malignancies and immunodeficienciesSeminars in Cell & Developmental Biology, 2008
- Somatic Mutations of JAK1 and JAK3 in Acute Leukemias and Solid CancersClinical Cancer Research, 2008
- Polymorphism in intron 1 of the interferon-gamma gene influences both serum immunoglobulin E levels and the risk for chronic hepatitis B virus infection in PolynesiansImmunogenetics, 2007
- Polymorphisms of type I interferon receptor 1 promoter and their effects on chronic hepatitis B virus infectionJournal of Hepatology, 2006
- Association of interferon-gamma gene haplotype in the Chinese population with hepatitis B virus infectionImmunogenetics, 2006
- A promoter polymorphism in the interferon α-2 gene is associated with the clinical presentation of hepatitis BMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2006
- JAK1 and Tyk2 Activation by the Homologous Polycythemia Vera JAK2 V617F MutationJournal of Biological Chemistry, 2005
- Hepatitis B Virus Infection — Natural History and Clinical ConsequencesNew England Journal of Medicine, 2004
- Two novel protein-tyrosine kinases, each with a second phosphotransferase-related catalytic domain, define a new class of protein kinase.Molecular and Cellular Biology, 1991
- A simple salting out procedure for extracting DNA from human nucleated cellsNucleic Acids Research, 1988